Muthu Vaduganathan
Oct 4, 2022
DELIVER presentations at HFSA
The DELIVER team presented 5 new papers at the Heart Failure Society of America in Washington, DC.
Dapagliflozin in Heart Failure with Improved Ejection Fraction The DELIVER Trial presented by Orly Vardeny
Time to Clinical Benefit of Dapagliflozin in Patients with HF with Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of DELIVER presented by Muthiah Vaduganathan
Effect of Dapagliflozin on Cause-Specific Mortality in Patients with Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER presented by Akshay Desai
Blood Pressure, Dapagliflozin, and Cardiovascular Outcomes In Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER presented by Senthil Selvaraj
Translating the Findings of the DELIVER Trial to Medicare Beneficiaries Hospitalized for HF in the United States presented by Muthiah Vaduganathan